These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23282746)

  • 1. May we strengthen the human natural defenses with bacterial lysates?
    Villa E; Garelli V; Braido F; Melioli G; Canonica GW
    World Allergy Organ J; 2010 Aug; 3(8 Suppl):S17-23. PubMed ID: 23282746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections.
    Braido F; Tarantini F; Ghiglione V; Melioli G; Canonica GW
    Int J Chron Obstruct Pulmon Dis; 2007; 2(3):335-45. PubMed ID: 18229572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed antibiotic prescriptions for respiratory infections.
    Spurling GK; Del Mar CB; Dooley L; Foxlee R; Farley R
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD004417. PubMed ID: 28881007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral infections and wheezing-asthma inception in childhood: is there a role for immunomodulation by oral bacterial lysates?
    Rossi GA; Pohunek P; Feleszko W; Ballarini S; Colin AA
    Clin Transl Allergy; 2020; 10():17. PubMed ID: 32509272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoregulatory and immunostimulatory responses of bacterial lysates in respiratory infections and asthma.
    Kearney SC; Dziekiewicz M; Feleszko W
    Ann Allergy Asthma Immunol; 2015 May; 114(5):364-9. PubMed ID: 25752734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.
    Smedemark SA; Aabenhus R; Llor C; Fournaise A; Olsen O; Jørgensen KJ
    Cochrane Database Syst Rev; 2022 Oct; 10(10):CD010130. PubMed ID: 36250577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis.
    Cazzola M; Anapurapu S; Page CP
    Pulm Pharmacol Ther; 2012 Feb; 25(1):62-8. PubMed ID: 22155205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed antibiotics for symptoms and complications of respiratory infections.
    Spurling GK; Del Mar CB; Dooley L; Foxlee R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004417. PubMed ID: 15495108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial lysates as a potentially effective approach in preventing acute exacerbation of COPD.
    Cazzola M; Capuano A; Rogliani P; Matera MG
    Curr Opin Pharmacol; 2012 Jun; 12(3):300-8. PubMed ID: 22365728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proteomic characterization of NTHi lysates.
    Preciado D; Poley M; Tsai S; Tomney A; Brown K; Val S
    Int J Pediatr Otorhinolaryngol; 2016 Jan; 80():8-16. PubMed ID: 26746604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.